Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment (Q34679106)

3 August 2017

Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment (English)

1 reference

mild cognitive impairment

3 August 2017

0 references

cognitive dysfunction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author

Alzheimer's Disease Neuroimaging Initiative

series ordinal

9

object named as

Alzheimer's Disease Neuroimaging Initiative

1 reference

3 August 2017

7

John Q Trojanowski

1 reference

3 August 2017

6

Leslie M Shaw

1 reference

3 August 2017

2

Michelle M Mielke

1 reference

3 August 2017

1

Ozioma C Okonkwo

1 reference

3 August 2017

4

Abhay R Moghekar

1 reference

3 August 2017

8

Marilyn S Albert

1 reference

3 August 2017

H Randall Griffith

3

1 reference

PubMed ID

21220682

3 August 2017

Richard J O'Brien

series ordinal

5

1 reference

3 August 2017

1 January 2011

1 reference

3 August 2017

Archives of Neurology

1 reference

3 August 2017

68

1 reference

3 August 2017

1

1 reference

3 August 2017

113-119

1 reference

Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

An update on treatment and prevention strategies for Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Outcome measures in clinical trials on medicinal products for the treatment of dementia: a European regulatory perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

So what if tangles precede plaques?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

CSF markers for incipient Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Geriatric Depression Scale.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Episodic and semantic memory: a comparison of amnesic and demented patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Use of CSF biomarkers in Alzheimer's disease clinical trials.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

The amyloid cascade hypothesis.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Mild cognitive impairment: to treat or not to treat

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Cerebrospinal fluid TAU protein and amyloid beta42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Biomarker profiles and their relation to clinical variables in mild cognitive impairment.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058271

Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21220682

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1001/ARCHNEUROL.2010.334

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

PubMed ID

21220682